WO2000077214A3 - Characterization of the yeast transcriptome - Google Patents

Characterization of the yeast transcriptome Download PDF

Info

Publication number
WO2000077214A3
WO2000077214A3 PCT/US2000/016223 US0016223W WO0077214A3 WO 2000077214 A3 WO2000077214 A3 WO 2000077214A3 US 0016223 W US0016223 W US 0016223W WO 0077214 A3 WO0077214 A3 WO 0077214A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell
cell cycle
characterization
transcriptome
yeast transcriptome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/016223
Other languages
French (fr)
Other versions
WO2000077214A2 (en
Inventor
Victor Velculescu
Bert Vogelstein
Kenneth Kinzler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Priority to JP2001503657A priority Critical patent/JP2003516716A/en
Priority to EP00939837A priority patent/EP1190044A2/en
Priority to CA002378512A priority patent/CA2378512A1/en
Priority to AU54856/00A priority patent/AU5485600A/en
Publication of WO2000077214A2 publication Critical patent/WO2000077214A2/en
Publication of WO2000077214A3 publication Critical patent/WO2000077214A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Yeast genes which are differentially expressed during the cell cycle are described. They can be used to study, affect, and monitor the cell cycle of a eukaryotic cell. They can be used to obtain human homologs involved in cell cycle regulation. They can be used to identify antifungal agents and other classes of drugs. They can be formed into arrays on solid supports for interrogation of a cell's transcriptome under various conditions.
PCT/US2000/016223 1999-06-16 2000-06-14 Characterization of the yeast transcriptome Ceased WO2000077214A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2001503657A JP2003516716A (en) 1999-06-16 2000-06-14 Characterization of the yeast transcriptome
EP00939837A EP1190044A2 (en) 1999-06-16 2000-06-14 Characterization of the yeast transcriptome
CA002378512A CA2378512A1 (en) 1999-06-16 2000-06-14 Characterization of the yeast transcriptome
AU54856/00A AU5485600A (en) 1999-06-16 2000-06-14 Characterization of the yeast transcriptome

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33503299A 1999-06-16 1999-06-16
US09/335,032 1999-06-16

Publications (2)

Publication Number Publication Date
WO2000077214A2 WO2000077214A2 (en) 2000-12-21
WO2000077214A3 true WO2000077214A3 (en) 2001-05-03

Family

ID=23309958

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/016223 Ceased WO2000077214A2 (en) 1999-06-16 2000-06-14 Characterization of the yeast transcriptome

Country Status (5)

Country Link
EP (1) EP1190044A2 (en)
JP (1) JP2003516716A (en)
AU (1) AU5485600A (en)
CA (1) CA2378512A1 (en)
WO (1) WO2000077214A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852536B2 (en) * 2001-12-18 2005-02-08 Isis Pharmaceuticals, Inc. Antisense modulation of CD36L 1 expression
JP2002272472A (en) * 2001-03-22 2002-09-24 Japan Science & Technology Corp Gene encoding sulfate ion transporter Sultr1; 3
FR2837492B1 (en) * 2002-03-21 2007-07-20 Commissariat Energie Atomique APICAL IODE TRANSPORTER AND ITS APPLICATIONS
DE60229920D1 (en) * 2002-05-21 2009-01-02 Mtm Lab Ag Marker for lung tumors
US20060147926A1 (en) 2002-11-25 2006-07-06 Emmert-Buck Michael R Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two-dimensional array
EP1922415B1 (en) * 2005-09-05 2013-12-25 Bio-Rad Innovations Use of both rd9 and is6110 as nucleic acid targets for the diagnosis of tuberculosis, and provision of multiplex-compliant is6110 and rd9 targets
WO2008047128A2 (en) * 2006-10-18 2008-04-24 Nazneen Rahman Materials and methods for determining susceptibility to cancer
US8188255B2 (en) 2006-10-20 2012-05-29 Exiqon A/S Human microRNAs associated with cancer
FR2947838B1 (en) 2009-07-08 2016-04-15 Clause MEANS AND METHODS FOR DETECTION AND IDENTIFICATION OF A NEW BACTERIUM RESPONSIBLE FOR PHYTOSANITARY DISEASES ON PLANTS (COURGETTES) AND NEW RESISTANT PLANTS
CN103200945B (en) 2010-03-24 2016-07-06 雷克西制药公司 RNA interference in ocular syndromes
EP3560503B1 (en) 2010-03-24 2021-11-17 Phio Pharmaceuticals Corp. Rna interference in dermal and fibrotic indications
WO2019054445A1 (en) * 2017-09-13 2019-03-21 大学共同利用機関法人情報・システム研究機構 Transgenic plant, method for producing transgenic plant, polynucleotide, polynucleotide cluster, vector, and kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998032847A2 (en) * 1997-01-23 1998-07-30 The Johns Hopkins University School Of Medicine Characterization of the yeast transcriptome

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998032847A2 (en) * 1997-01-23 1998-07-30 The Johns Hopkins University School Of Medicine Characterization of the yeast transcriptome

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
V.E.VCELCULESCU ET AL.: "Characterization of the yeast transcriptome", CELL, vol. 88, 24 January 1997 (1997-01-24), CELL PRESS,CAMBRIDGE,MA,US;, pages 243 - 251, XP002070903 *

Also Published As

Publication number Publication date
WO2000077214A2 (en) 2000-12-21
CA2378512A1 (en) 2000-12-21
JP2003516716A (en) 2003-05-20
EP1190044A2 (en) 2002-03-27
AU5485600A (en) 2001-01-02

Similar Documents

Publication Publication Date Title
WO2000077214A3 (en) Characterization of the yeast transcriptome
Shustik et al. P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation
AU3997300A (en) Gene sequence variations with utility in determining the treatment of disease
CA2335393A1 (en) Liposomal encapsulated nucleic acid-complexes
CA2347979A1 (en) Treatment of skin with adenosine or adenosine analog
WO2002051332A3 (en) Compress garment facilitating the use of medical electrodes
CA2352964A1 (en) A method for enhancing protective cellular responses to genotoxic stress in skin
WO2003008647A3 (en) Blood assessment of injury
WO2001016345A3 (en) Sequence-specific dna recombination in eukaryotic cells
WO1996003515A3 (en) Surface expression of enzyme in gene directed prodrug therapy
PL327624A1 (en) Cells suitable for use in genotherapy, their aplication in production of a pharmaceutic agent, method of obtaining such cells, pharmaceutic agent and method of obtaining the lastmentioned one
HU9700429D0 (en) Nucleic acid constructs for the cell cycleregulated expression of genes, cells containing such constructs and their use for preparing drugs
WO1998013488A3 (en) Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
AU5394100A (en) Fatty acid elongation genes and uses thereof
IL156557A0 (en) Bax-responsive genes for drug target identification in yeast and fungi
WO1998032847A3 (en) Characterization of the yeast transcriptome
WO2000078119A3 (en) Cardiomyocytes with enhanced proliferative potential
AU7437900A (en) Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and others uses
WO1998046747A3 (en) Genes in the non-recombining region of the y chromosome
AU3622297A (en) Sequential hybridization of fungal cell DNA, and method for detecting fungal cells in clinical material
ITTO950645A0 (en) ELECTRODE FOR THE ACQUISITION OF AN ELECTRICAL BIOLOGICAL SIGNAL, IN PARTICULAR AN ELECTROCARDIOGRAPHIC SIGNAL.
AU3590000A (en) Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
AU7625600A (en) Electrochemical cell and cell assembly process
WO2000063348A3 (en) Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
AU7009600A (en) Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2378512

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 54856/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000939837

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000939837

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000939837

Country of ref document: EP